Quantification of inaccurate diagnosis of COPD in primary care medicine: an analysis of the COACH clinical audit

References

• Hangaard S, Helle T, Nielsen C, Hejlesen OK. Causes of misdiagnosis of chronic obstructive pulmonary disease: a systematic scoping review. Respir Med. 2017;129:63–84. doi:10.1016/j.rmed.2017.05.01528732838
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53(3):128–149. doi:10.1016/j.arbres.2017.02.00128274597
   PubMed Web of Science ®Google Scholar
• Casas Herrera A, Montes de Oca M, Lopez VMV, et al. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American Countries. a key to enhance disease diagnosis: the PUMA study. PLoS One. 2016;11(4):e0152266.27073880
   PubMed Web of Science ®Google Scholar
• Fu SN, Yu WC, Wong CK, Lam MC. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting. Int J Chron Obstruct Pulmon Dis. 2016;11:2391–2399. doi:10.2147/COPD.S10630627729780
   PubMed Web of Science ®Google Scholar
• Llordes M, Jaen A, Almagro P, et al. Prevalence, risk factors and diagnostic accuracy of COPD among smokers in primary care. Copd. 2015;12(4):404–412. doi:10.3109/15412555.2014.97473625474184
   PubMedGoogle Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-319716965
   PubMed Web of Science ®Google Scholar
• Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015;36(4):575–591. doi:10.1055/s-0035-155606326238643
   PubMed Web of Science ®Google Scholar
• Colak Y, Afzal S, Nordestgaard BG, et al. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med. 2017;5(5):426–434. doi:10.1016/S2213-2600(17)30119-428389225
   PubMed Web of Science ®Google Scholar
• Fernandez-Villar A, Soriano JB, Lopez-Campos JL. Overdiagnosis of COPD: precise definitions and proposals for improvement. Br J Gen Pract. 2017;67(657):183–184. doi:10.3399/bjgp17X69038928360069
   PubMed Web of Science ®Google Scholar
• Fernandez-Villar A, Lopez-Campos JL, Represas Represas C, et al. Factors associated with inadequate diagnosis of COPD: on-sint cohort analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:961–967. doi:10.2147/COPD.S7954726028969
   PubMed Web of Science ®Google Scholar
• Enright P. Patients are hurt by a false diagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(2):229. doi:10.1164/rccm.201306-1150OC24428652
   PubMed Web of Science ®Google Scholar
• Fisk M, McMillan V, Brown J, et al. Inaccurate diagnosis of COPD: the Welsh National COPD Audit. Br J Gen Pract. 2019;69(678):e1–e7. doi:10.3399/bjgp18X70038530559109
   PubMed Web of Science ®Google Scholar
• Abad-Arranz M, Moran-Rodriguez A, Mascaros Balaguer E, et al. Community assessment of COPD health care (COACH) study: a clinical audit on primary care performance variability in COPD care. BMC Med Res Methodol. 2018;18(1):68.29970023
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol. 2014;50(Suppl 1):1–16. doi:10.1016/S0300-2896(14)70070-5
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.3558716
   PubMedGoogle Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC22561964
   PubMed Web of Science ®Google Scholar
• Merlo J. Multilevel analytical approaches in social epidemiology: measures of health variation compared with traditional measures of association. J Epidemiol Community Health. 2003;57(8):550–552.12883048
   PubMed Web of Science ®Google Scholar
• Lee TM, Tu K, Wing LL, Gershon AS. Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study. NPJ Prim Care Respir Med. 2017;27(1):34.28507288
   PubMed Web of Science ®Google Scholar
• Echazarreta AL, Arias SJ, Del Olmo R, et al. Prevalence of COPD in 6 urban clusters in Argentina: the EPOC.AR study. Arch Bronconeumol. 2018;54(5):260–269. doi:10.1016/j.arbres.2017.09.01829221827
   PubMed Web of Science ®Google Scholar
• Santurtun A, Rasilla DF, Riancho L, Zarrabeitia MT. Relationship between chronic obstructive pulmonary disease and air pollutants depending on the origin and trajectory of air masses in the north of Spain. Arch Bronconeumol. 2017;53(11):616–621. doi:10.1016/j.arbres.2017.03.01728495075
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol. 2017;53(6):324–335. doi:10.1016/j.arbres.2017.03.01828477954
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Soriano JB, Calle M. Encuesta de Espirometria en Espana P. A comprehensive, national survey of spirometry in Spain: current bottlenecks and future directions in primary and secondary care. Chest. 2013;144(2):601–609. doi:10.1378/chest.12-269023411500
   PubMed Web of Science ®Google Scholar
• Hidalgo Sierra V, Hernandez Mezquita MA, Palomo Cobos L, et al. Usefulness of the piko-6 portable device for early COPD detection in primary care. Arch Bronconeumol. 2018. doi:10.1016/j.arbr.2018.07.008
   Web of Science ®Google Scholar
• Kjeldgaard P, Lykkegaard J, Spillemose H, Ulrik CS. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care? Int J Chron Obstruct Pulmon Dis. 2017;12:2323–2331. doi:10.2147/COPD.S13624428831249
   PubMed Web of Science ®Google Scholar
• Schermer TR, Vatsolaki M, Behr R, et al. Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial. NPJ Prim Care Respir Med. 2018;28(1):17.29789607
   PubMed Web of Science ®Google Scholar
• Thorat YT, Salvi SS, Kodgule RR. Peak flow meter with a questionnaire and mini-spirometer to help detect asthma and COPD in real-life clinical practice: a cross-sectional study. NPJ Prim Care Respir Med. 2017;27(1):32. doi:10.1038/s41533-017-0036-828487516
   PubMed Web of Science ®Google Scholar
• Sogbetun F, Eschenbacher WL, Welge JA, Panos RJ. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease. Respir Med. 2016;120:1–9. doi:10.1016/j.rmed.2016.09.01027817804
   PubMed Web of Science ®Google Scholar
• Spyratos D, Haidich AB, Chloros D, et al. Comparison of three screening questionnaires for chronic obstructive pulmonary disease in the primary care. Respiration. 2017;93(2):83–89. doi:10.1159/00045358628052294
   PubMed Web of Science ®Google Scholar
• Izquierdo JL, Miravitlles M, Esquinas C, et al. Characteristics of COPD patients managed in respiratory medicine departments in Spain, according to GOLD groups and GesEPOC clinical phenotypes. Arch Bronconeumol. 2018. doi:10.1016/j.arbr.2018.09.006
   Web of Science ®Google Scholar
• Kouijzer M, Brusse-Keizer M, Bode C. COPD-related fatigue: impact on daily life and treatment opportunities from the patient‘s perspective. Respir Med. 2018;141:47–51. doi:10.1016/j.rmed.2018.06.01130053971
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Puente Maestu L, Roman-Rodriguez M, et al. Creation of the SAQ-COPD questionnaire to determine physical activity in COPD patients in clinical practice. Arch Bronconeumol. 2018. doi:10.1016/j.arbr.2018.07.003
   Web of Science ®Google Scholar
• Rabinovich RA. Physical activity in COPD. Significance, prognosis, measurement and therapeutic interventions. Arch Bronconeumol. 2018;54(9):449–450. doi:10.1016/j.arbres.2018.01.01129503063
   PubMed Web of Science ®Google Scholar
• Carrion Valero F, Paulos Dos Santos S, Celli BR. Smoking in COPD patients: a new clinical phenotype? Arch Bronconeumol. 2018;54(5):249–250. doi:10.1016/j.arbres.2017.10.02129217210
   PubMed Web of Science ®Google Scholar
• Rossi A, Butorac-Petanjek B, Chilosi M, et al. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies. Int J Chron Obstruct Pulmon Dis. 2017;12:2593–2610. doi:10.2147/COPD.S13223628919728
   PubMed Web of Science ®Google Scholar
• Hanlon P, Nicholl BI, Jani BD, et al. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open. 2018;8(1):e018404. doi:10.1136/bmjopen-2017-018404
   PubMed Web of Science ®Google Scholar
• Divo MJ, Celli BR, Poblador-Plou B, et al. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the EpiChron cohort. PLoS One. 2018;13(2):e0193143.29470502
   PubMed Web of Science ®Google Scholar